Page last updated: 2024-10-24

carmustine and Autosomal Recessive Chronic Granulomatous Disease

carmustine has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 2 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dallegri, F1
Patrone, F1
Frumento, G1
Sacchetti, C1
Roberts, RL1
Aroda, VR1
Ank, BJ1

Other Studies

2 other studies available for carmustine and Autosomal Recessive Chronic Granulomatous Disease

ArticleYear
Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms.
    Journal of the National Cancer Institute, 1984, Volume: 73, Issue:2

    Topics: Antibody-Dependent Cell Cytotoxicity; Aprotinin; Blood Glucose; Burkitt Lymphoma; Carmustine; Cell L

1984
N-acetylcysteine enhances antibody-dependent cellular cytotoxicity in neutrophils and mononuclear cells from healthy adults and human immunodeficiency virus-infected patients.
    The Journal of infectious diseases, 1995, Volume: 172, Issue:6

    Topics: Acetylcysteine; Adolescent; Adult; Antibody-Dependent Cell Cytotoxicity; Antioxidants; Carmustine; C

1995